Abstract | BACKGROUND/AIMS: The efficacy and safety of a combination of ezetimibe and low-dose statin as primary treatment for dyslipidemia in renal transplant patients were evaluated prospectively. METHODS: RESULTS: CONCLUSIONS:
|
Authors | Hye Eun Yoon, Joon Chang Song, Bok Jin Hyoung, Hyeon Seok Hwang, So Young Lee, Youn Joo Jeon, Bum Soon Choi, Yong Soo Kim, Chul Woo Yang |
Journal | The Korean journal of internal medicine
(Korean J Intern Med)
Vol. 24
Issue 3
Pg. 233-7
(Sep 2009)
ISSN: 1226-3303 [Print] Korea (South) |
PMID | 19721860
(Publication Type: Journal Article)
|
Chemical References |
- Azetidines
- Cholesterol, LDL
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- C-Reactive Protein
- Simvastatin
- Ezetimibe
|
Topics |
- Adult
- Azetidines
(administration & dosage, adverse effects)
- C-Reactive Protein
(analysis)
- Cholesterol, LDL
(blood)
- Dyslipidemias
(blood, drug therapy)
- Ezetimibe
- Female
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(administration & dosage)
- Kidney Transplantation
- Male
- Middle Aged
- Prospective Studies
- Simvastatin
(administration & dosage, adverse effects)
|